123 related articles for article (PubMed ID: 34262818)
1. A Case Series of Multiple Primary Malignancies Among Patients With Advanced Melanoma.
Ebia MI; Capone S; Ricker C; Thomas JS; Tulpule V; Kang I; D'Souza A; Freyer DR; Miller K; In GK
Cureus; 2021 Jun; 13(6):e15480. PubMed ID: 34262818
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and survival of patients with multiple primary malignancies.
Wang XK; Zhou MH
World J Clin Cases; 2021 Dec; 9(34):10484-10493. PubMed ID: 35004980
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of Clinical Characteristics of Lung Cancer Combined with
Multiple Primary Malignancies in Other Organs].
Zhang S; Xu Z; Dong G; Li M; Xu L
Zhongguo Fei Ai Za Zhi; 2021 Jan; 24(1):7-12. PubMed ID: 33478184
[TBL] [Abstract][Full Text] [Related]
4. Multiple primary malignancies involving lung cancer.
Li F; Zhong WZ; Niu FY; Zhao N; Yang JJ; Yan HH; Wu YL
BMC Cancer; 2015 Oct; 15():696. PubMed ID: 26466785
[TBL] [Abstract][Full Text] [Related]
5. Multiple primary tumors in differentiated thyroid carcinoma and relationship to thyroid cancer outcome.
Omür O; Ozcan Z; Yazici B; Akgün A; Oral A; Ozkiliç H
Endocr J; 2008 May; 55(2):365-72. PubMed ID: 18277003
[TBL] [Abstract][Full Text] [Related]
6. Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma: A Largest Series With 26-Year Follow-Up.
Xu W; Liao W; Ge P; Ren J; Xu H; Yang H; Sang X; Lu X; Mao Y
Medicine (Baltimore); 2016 Apr; 95(17):e3491. PubMed ID: 27124050
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of multiple primary malignancies: a retrospective analysis of 72 Chinese patients.
Jiao F; Yao LJ; Zhou J; Hu H; Wang LW
Asian Pac J Cancer Prev; 2014; 15(1):331-4. PubMed ID: 24528052
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience.
Skelton WP; Ali A; Skelton MN; Federico R; Bosse R; Nguyen TC; Dang LH; Bishnoi R
Cureus; 2019 Apr; 11(4):e4552. PubMed ID: 31275776
[TBL] [Abstract][Full Text] [Related]
9. Synchronous and metachronous malignancies: analysis of the Minneapolis Veterans Affairs (VA) tumor registry.
Powell S; Tarchand G; Rector T; Klein M
Cancer Causes Control; 2013 Aug; 24(8):1565-73. PubMed ID: 23737025
[TBL] [Abstract][Full Text] [Related]
10. Second primary melanomas: incidence and outcome.
Bower MR; Scoggins CR; Martin RC; Mays MP; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Noyes RD; Sussman JJ; Hagendoorn LJ; Stromberg AJ; McMasters K
Am Surg; 2010 Jul; 76(7):675-81. PubMed ID: 20698369
[TBL] [Abstract][Full Text] [Related]
11. Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.
Helgadottir H; Tuominen R; Olsson H; Hansson J; Höiom V
J Am Acad Dermatol; 2017 Nov; 77(5):893-901. PubMed ID: 28818438
[TBL] [Abstract][Full Text] [Related]
12. Multiple Primary Malignancies in Renal Transplant Recipients: a Single Centre Retrospective Cohort Study.
Basic-Jukic N; Kirincich J; Jelakovic B; Kastelan Z
Kidney Blood Press Res; 2018; 43(3):1034-1041. PubMed ID: 29940589
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and survival of second primary breast carcinoma with extramammary malignancies.
Jing Y; Wang X; Sun B
Front Oncol; 2023; 13():1160370. PubMed ID: 37007094
[TBL] [Abstract][Full Text] [Related]
14. Use of extracranial radiation therapy in metastatic melanoma patients receiving immunotherapy.
Gabani P; Robinson CG; Ansstas G; Johanns TM; Huang J
Radiother Oncol; 2018 May; 127(2):310-317. PubMed ID: 29534829
[TBL] [Abstract][Full Text] [Related]
15. Multiple Primary Melanomas: Retrospective Review in a Tertiary Care Hospital.
Palacios-Diaz RD; de Unamuno-Bustos B; Abril-Pérez C; Pozuelo-Ruiz M; Sánchez-Arraez J; Torres-Navarro I; Botella-Estrada R
J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566480
[TBL] [Abstract][Full Text] [Related]
16. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.
Schaule J; Kroeze SGC; Blanck O; Stera S; Kahl KH; Roeder F; Combs SE; Kaul D; Claes A; Schymalla MM; Adebahr S; Eckert F; Lohaus F; Abbasi-Senger N; Henke G; Szuecs M; Geier M; Sundahl N; Buergy D; Dummer R; Guckenberger M
Radiat Oncol; 2020 Jun; 15(1):135. PubMed ID: 32487100
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of and risk factors for multiple primary melanomas.
Ferrone CR; Ben Porat L; Panageas KS; Berwick M; Halpern AC; Patel A; Coit DG
JAMA; 2005 Oct; 294(13):1647-54. PubMed ID: 16204664
[TBL] [Abstract][Full Text] [Related]
18. Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables.
Gandhi S; Abhyankar A; Basu S
Nucl Med Commun; 2014 Feb; 35(2):205-9. PubMed ID: 24217429
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features and Survival of Multiple Primary Melanoma: A Belgian Single Center Cohort.
Absil G; Collins P; Seidel L; Damsin T; Nikkels AF
Dermatol Ther (Heidelb); 2023 Feb; 13(2):641-649. PubMed ID: 36609959
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and prognostic indicators for metastatic melanoma: data from 446 patients in north China.
Hao M; Zhao G; Du X; Yang Y; Yang J
Tumour Biol; 2016 Aug; 37(8):10339-48. PubMed ID: 26846098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
